Neuren Pharmaceuticals Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was AUD 14.55 million. Revenue was AUD 17.03 million compared to AUD 3.64 million a year ago.

Net income was AUD 0.184 million compared to net loss of AUD 7.79 million a year ago. Basic earnings per share from continuing operations was AUD 0.001 compared to basic loss per share from continuing operations of AUD 0.066 a year ago. Diluted earnings per share from continuing operations was AUD 0.001 compared to diluted loss per share from continuing operations of AUD 0.066 a year ago.